Literature DB >> 2862096

Peripheral blood mononuclear cells and regulatory T cells in acute viral hepatitis.

V Barnaba, E Tamburrini, V Laghi, R Cauda, M Levrero, G Ruocco, L Ortona, F Balsano.   

Abstract

During acute viral hepatitis, we observed a significant decrease in OKT4/OKT8 ratio with a significant increase in the OKT8 positive subset in acute type B and non-A-non-B hepatitis. This altered ratio persisted in type B for a long time until HBsAg antibody became detectable, while it soon returned to normal in type A and non-A-non-B hepatitis. In the majority of acute hepatitis the altered ratio is because of an increase and not to a decrease in the whole T cell population, as described in chronic HBV infection. The number of HNK-1 positive cells remained raised during the recovery phase of type B and non-A-non-B hepatitis, a finding consistent with the hypothesis that NK cells play a role in the host defence against B and non-A-non-B virus infections. Serum beta 2-microglobulin concentrations were increased only in acute hepatitis B and non-A-non-B where immunological mechanisms are suspected to be involved, and showed a good correlation with the population of activated OKIa positive cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862096      PMCID: PMC1433006          DOI: 10.1136/gut.26.7.739

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Presence of HBeAg, DNA polymerase activity, Dane particle in different categories of HBsAg carriers and evidence of hepatitis type B infection in their family contacts.

Authors:  A R Zanetti; P Ferroni
Journal:  Boll Ist Sieroter Milan       Date:  1977-03-31

2.  Synthesis of 2 -microglobulin by stimulated lymphocytes.

Authors:  G M Bernier; M W Fanger
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

3.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

4.  Suppressor cell activity in viral and non-viral chronic active hepatitis.

Authors:  F Tremolada; G Fattovich; G Panebianco; G Ongaro; G Realdi
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

5.  Serum beta2-microglobulin in liver disease.

Authors:  R Hällgren
Journal:  Scand J Clin Lab Invest       Date:  1979-09       Impact factor: 1.713

6.  DNA polymerase associated with human hepatitis B antigen.

Authors:  P M Kaplan; R L Greenman; J L Gerin; R H Purcell; W S Robinson
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

7.  Abnormalities of immunoregulatory T cells in disorders of immune function.

Authors:  E L Reinherz; A Rubinstein; R S Geha; A J Strelkauskas; F S Rosen; S F Schlossman
Journal:  N Engl J Med       Date:  1979-11-08       Impact factor: 91.245

8.  Immunoregulatory T-cell function in acute and chronic liver disease.

Authors:  S Kakumu; K Yata; T Kashio
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

9.  beta2-Microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens.

Authors:  K Kin; T Kasahara; Y Itoh; I Sakurabayashi; T Kawai; M Morita
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

10.  Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.

Authors:  F V Chisari; K L Castle; C Xavier; D S Anderson
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.